Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

NCT06973356 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Immune Thrombocytopenia (ITP)

Interventions

DRUG: Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis.

Sponsor

Anhui Provincial Hospital